Major Depressive Disorder Study
Seltorexant as an Adjunctive Treatment for MDD with Insomnia Symptoms
Michigan Clinical Research Institute is currently enrolling for a clinical research study for adults ages 18-74 who have been diagnosed with Major Depressive Disorder (MDD) and have Insomnia symptoms.
An individual may qualify for the study if they:
- Are 18 to 74 years of age
- Have been diagnosed with Major Depressive Disorder (MDD) and have Insomnia symptoms
- Have had an inadequate response to 1-2 antidepressants
- Meet additional study criteria
Reimbursement for reasonable, out-of-pocket expenses such as travel and accommodations may be available to qualified individuals.
Contact us or fill out the form below so we can reach out to you and move forward with pre-screening questions to assess your overall eligibility.